ReviewFrontiers in oncology2018

Vγ9Vδ2 T Cells as Strategic Weapons to Improve the Potency of Immune Checkpoint Blockade and Immune Interventions in Human Myeloma.

Barbara Castella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.